Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA,Tyr]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

about

Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA,Tyr]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

Item

http://www.wikidata.org/entity/Q58801951

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Patient-specific image-based b ...... of a new hybrid image approach

@en

Patient-specific image-based b ...... of a new hybrid image approach

@nl

type

Item

label

Patient-specific image-based b ...... of a new hybrid image approach

@en

Patient-specific image-based b ...... of a new hybrid image approach

@nl

prefLabel

Patient-specific image-based b ...... of a new hybrid image approach

@en

Patient-specific image-based b ...... of a new hybrid image approach

@nl

P1476

Patient-specific image-based b ...... of a new hybrid image approach

@en

P2093

Andreas Delker

http://www.w3.org/2001/XMLSchema#string

Andrei Todica

http://www.w3.org/2001/XMLSchema#string

Anika Brunegraf

http://www.w3.org/2001/XMLSchema#string

Astrid Gosewisch

http://www.w3.org/2001/XMLSchema#string

Franz Josef Gildehaus

http://www.w3.org/2001/XMLSchema#string

Guido Böning

http://www.w3.org/2001/XMLSchema#string

Harun Ilhan

http://www.w3.org/2001/XMLSchema#string

Julia Brosch

http://www.w3.org/2001/XMLSchema#string

Lena Vomacka

http://www.w3.org/2001/XMLSchema#string

Peter Bartenstein

http://www.w3.org/2001/XMLSchema#string

P2860

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry.

MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy

Dosimetry in Peptide radionuclide receptor therapy: a review.

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.

P2888

s13550-018-0427-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13550-018-0427-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105975693

http://www.w3.org/2001/XMLSchema#string

P698

30076556

http://www.w3.org/2001/XMLSchema#string

P932

6081875

http://www.w3.org/2001/XMLSchema#string